Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|February 16, 2020
CCL3 Signaling in the Tumor MicroenvironmentIoannis Ntanasis-Stathopoulos, Despoina Fotiou, Evangelos Terpos
Expert Review of Hematology|July 19, 2016
Managing renal complications in multiple myelomaDespoina Fotiou, Meletios A Dimopoulos, Efstathios Kastritis
Aging|December 21, 2018
How I treat elderly patients with plasma cell dyscrasiasMaria Gavriatopoulou, Despoina Fotiou, Ioannis Ntanasis-Stathopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 30, 2020
Monitoring Plasma Cell Dyscrasias With Cell-free DNA AnalysisIoannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Terpos, et al.
Blood|June 15, 2026
A Phase 2 trial of daratumumab monotherapy in newly diagnosed patients with cardiac stage IIIb AL amyloidosisEfstathios Kastritis, Monique C Minnema, Meletios-Athanasios A Dimopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 19, 2018
Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WMMaria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
Haematologica|October 30, 2016
Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myelomaEfstathios Kastritis, Evangelos Terpos, Maria Roussou, et al.
American Journal of Hematology|February 19, 2016
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysisMeletios A Dimopoulos, Maria Roussou, Maria Gavriatopoulou, et al.
Leukemia & Lymphoma|September 1, 2023
Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantationEvangelos Eleutherakis Papaiakovou, Evangelos Terpos, Nikolaos Kanellias, et al.
Leukemia & Lymphoma|December 15, 2016
Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimensDimitrios C Ziogas, Efstathios Kastritis, Evangelos Terpos, et al.
Pageof 2